TY - JOUR
T1 - Colorectal liver metastases with a disrupted circadian rhythm phase shift the peripheral clock in liver and kidney
AU - Huisman, Sander
AU - Oklejewicz, Gosia
AU - Ahmadi, Ali
AU - Tamanini, Filippo
AU - IJzermans, J.N.M.
AU - van der Horst, Bert
AU - de Bruin, Ron
PY - 2015
Y1 - 2015
N2 - Circadian clock genes regulate 10-15% of the transcriptome, and might function as tumor suppressor genes. Relatively little is known about the circadian clock in tumors and its effect on surrounding healthy tissues. Therefore, we compared the 24-hr expression levels of key circadian clock genes in liver and kidney of healthy control mice with those of mice bearing C26 colorectal tumor metastases in the liver. Metastases were induced by injection of C26 colorectal carcinoma cells into the spleen. Subsequently, tumor, liver and kidney tissue was collected around the clock to compare circadian rhythmicity. Expression levels of five clock genes (Rev-Erb, Per1, Per2, Bmal1 and Cry1) and three clock-controlled genes (CCGs; Dbp, p21 and Wee1) were determined by qRT-PCR. Liver and kidney tissue of healthy control mice showed normal 24-hr oscillations of all clock genes and CCGs, consistent with normal circadian rhythmicity. In colorectal liver metastases, however, 24-hr oscillations were completely absent for all clock genes and CCGs except Cry1. Liver and kidney tissue of tumor-bearing mice showed a shift in clock periodicity relative to control mice. In the liver we observed a phase advance, whereas in the kidney the phase was delayed. These data show that hepatic metastases of C26 colon carcinoma with a disrupted circadian rhythm phase shift liver and kidney tissue clocks, which strongly suggests a systemic effect on peripheral clocks. The possibility that tumors may modify peripheral clocks to escape from ordinary circadian rhythms and in this way contribute to fatigue and sleep disorders in cancer patients is discussed. What's new? Disruption of the molecular circadian clock is linked to tumor development, with possible associations between circadian organization and cancer type. This study examined the expression of circadian clock genes in mice bearing C26 colorectal tumor liver metastases. For nearly all clock genes studied, normal 24-hour oscillations in expression were found to be absent in mice with hepatic metastases. Shifts in clock periodicity were detected in both liver and kidney tissue. The results indicate that tumor-associated circadian disruption may be systemic, with tumors potentially manipulating nearby cells, facilitating their escape from normal circadian rhythms.
AB - Circadian clock genes regulate 10-15% of the transcriptome, and might function as tumor suppressor genes. Relatively little is known about the circadian clock in tumors and its effect on surrounding healthy tissues. Therefore, we compared the 24-hr expression levels of key circadian clock genes in liver and kidney of healthy control mice with those of mice bearing C26 colorectal tumor metastases in the liver. Metastases were induced by injection of C26 colorectal carcinoma cells into the spleen. Subsequently, tumor, liver and kidney tissue was collected around the clock to compare circadian rhythmicity. Expression levels of five clock genes (Rev-Erb, Per1, Per2, Bmal1 and Cry1) and three clock-controlled genes (CCGs; Dbp, p21 and Wee1) were determined by qRT-PCR. Liver and kidney tissue of healthy control mice showed normal 24-hr oscillations of all clock genes and CCGs, consistent with normal circadian rhythmicity. In colorectal liver metastases, however, 24-hr oscillations were completely absent for all clock genes and CCGs except Cry1. Liver and kidney tissue of tumor-bearing mice showed a shift in clock periodicity relative to control mice. In the liver we observed a phase advance, whereas in the kidney the phase was delayed. These data show that hepatic metastases of C26 colon carcinoma with a disrupted circadian rhythm phase shift liver and kidney tissue clocks, which strongly suggests a systemic effect on peripheral clocks. The possibility that tumors may modify peripheral clocks to escape from ordinary circadian rhythms and in this way contribute to fatigue and sleep disorders in cancer patients is discussed. What's new? Disruption of the molecular circadian clock is linked to tumor development, with possible associations between circadian organization and cancer type. This study examined the expression of circadian clock genes in mice bearing C26 colorectal tumor liver metastases. For nearly all clock genes studied, normal 24-hour oscillations in expression were found to be absent in mice with hepatic metastases. Shifts in clock periodicity were detected in both liver and kidney tissue. The results indicate that tumor-associated circadian disruption may be systemic, with tumors potentially manipulating nearby cells, facilitating their escape from normal circadian rhythms.
U2 - 10.1002/ijc.29089
DO - 10.1002/ijc.29089
M3 - Article
SN - 0020-7136
VL - 136
SP - 1024
EP - 1032
JO - International Journal of Cancer
JF - International Journal of Cancer
IS - 5
ER -